The Nuclear Control of Cell Growth and Differentiation (NC) Program is a laboratory-based, basic science program focused on the genetic basis of cancer with collaborative connections to all other programs within Huntsman Cancer Institute. The research goal is to investigate fundamental mechanisms in the nucleus that go awry in the cancer cell that may be exploited to impact new approaches to cancer prevention, diagnostics, prognostics, and treatment. Areas of particular emphasis include maintenance of genome stability, including DNA damage and repair;epigenetic involving DNA methylation and chromatin dynamics;transcripfional regulation of gene expression through sequence-specific DNA binding proteins, including ones implicated in human cancer;and analysis of transcriptional networks that drive embryonic development, organogenesis, and cell metabolism. The NC Program has depth and strength in all major experimental approaches, including basic chemistry and biochemistry;structural biology;molecular, cell, and cancer biology;genetic and genomic approaches;and the use of animal systems for discovery and validation of cancer pathways in humans. Major achievements over the last five years include discovery of a DNA demethylase that directs epigenetic programming and is associated with cancer progression, elucidation of critical downstream targets of oncogenic transcription factors in the ETS family in the context of sarcoma and prostate cancer, and creation of mouse models of sarcoma through pioneering gene targeting technologies. Led by Barbara Graves, PhD, and Stephen Lessnick, MD, PhD, the Program has 23 members from nine departments and two colleges. There are three HHMI Investigators. As of December 2008, NC members had $9.8M in peer-reviewed annual direct costs for research projects, including 11% from NCI. Since July 2003, their research has been reported in 220 publications, of which 9% were intra- and 14% were interprogrammatic collaborations. Six new members are MD/PhDs, including the Co-Leader, and bring a clinical perspective to the Program. More than 90% of members have peer-reviewed funding and several members have highly distinguished awards, including the Nobel Prize in Medicine or Physiology, awarded to Mario Capecchi, PhD, for his pioneering work in gene targeting in 2007. The Cancer Center enhances the research goals and integration of this Program through fostering collaborative and transdisciplinary interactions as well as providing access to shared resources, NC programmatic funds, and support for faculty recruitments. In the next five years, the NC Program will continue initiatives to elucidate basic cancer mechanisms and to educate both Center members, as well as the next generation of cancer researchers, with the ultimate goal of impacting the care of cancer patients within an individualized oncology paradigm.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-24
Application #
8465109
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
24
Fiscal Year
2013
Total Cost
$41,476
Indirect Cost
$21,836
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Warner, Echo L; Ding, Qian; Pappas, Lisa et al. (2017) Health Care Providers' Knowledge of HPV Vaccination, Barriers, and Strategies in a State With Low HPV Vaccine Receipt: Mixed-Methods Study. JMIR Cancer 3:e12
Affolter, Kajsa; Gligorich, Keith; Samadder, Niloy Jewel et al. (2017) Feasibility of Large-Scale Identification of Sessile Serrated Polyp Patients Using Electronic Records: A Utah Study. Dig Dis Sci 62:1455-1463
Fowler, Brynn; Samadder, N Jewel; Kepka, Deanna et al. (2017) Improvements in Colorectal Cancer Incidence Not Experienced by Nonmetropolitan Women: A Population-Based Study From Utah. J Rural Health :
Ou, Judy Y; Smits-Seemann, Rochelle R; Kaul, Sapna et al. (2017) Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample. Cancer Epidemiol 49:216-224
VanderLinden, Ryan T; Hemmis, Casey W; Yao, Tingting et al. (2017) Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism. J Biol Chem 292:9493-9504
Cohen, Adam L; Factor, Rachel E; Mooney, Kathi et al. (2017) POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast 31:219-223
Gardiner, Jamie D; Abegglen, Lisa M; Huang, Xiaomeng et al. (2017) C/EBP?-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget 8:26013-26026
Ding, Yun; Fleming, Aaron M; Burrows, Cynthia J (2017) Sequencing the Mouse Genome for the Oxidatively Modified Base 8-Oxo-7,8-dihydroguanine by OG-Seq. J Am Chem Soc 139:2569-2572
Carleton, Julia B; Berrett, Kristofer C; Gertz, Jason (2017) Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor ?-Bound Enhancers. Cell Syst 5:333-344.e5
Lai, Run-Zhi; Han, Xue-Sheng; Dahlquist, Frederick W et al. (2017) Paradoxical enhancement of chemoreceptor detection sensitivity by a sensory adaptation enzyme. Proc Natl Acad Sci U S A 114:E7583-E7591

Showing the most recent 10 out of 1113 publications